Endometriosis NewsNews on Endometriosis continually updated from thousands of sources around the net.What's With Efficacy CapitalRepros Therapeutics' Standstill Agreement- January 22, 2008 Is $121.4 million the right market cap for a biotech which has identified $3.5 billion in annual revenues possible from its lead pipeline prospect Apparently San Diego, CA, hedge fund Efficacy Capital, Ltd. via Seeking Alphahttp://www.topix.net/health/endometriosis/2008/01/whats-with-efficacy-capital-repros-thera... |